Saphyre Founders Gabino Roche and Stephen Roche Inducted into Seton Hall University Entrepreneur Hall of Fame

Saphyre Founders Gabino Roche and Stephen Roche Inducted into Seton Hall University Entrepreneur Hall of Fame HOBOKEN, N.J., April 19, 2023 /PRNewswire/ — Seton Hall University has announced the induction of Gabino Roche Jr. and Stephen Roche into the 2023 Entrepreneur Hall of Fame Awards for their outstanding contribution to the fintech industry through Saphyre,…

Read More

Breaking News: Molekule Wins Court Case Against Competitor’s Trademark Infringement Complaint!

Molekule Announces Court Ordered Dismissal of Competitor’s Trademark Infringement Complaint Exciting News from Molekule Good day, readers! Have you heard the latest scoop from Molekule? The Company has recently announced that a civil complaint filed against them for trademark infringement has been favorably resolved. This is truly a victory for Molekule and a significant milestone…

Read More

Uncovering the Truth: Holzer Holzer LLC Launches Investigation into Shift4 Payments Inc. (FOUR)

Investigation of Shift4 Payments, Inc. (FOUR) Announced by Holzer & Holzer, LLC ATLANTA, April 19, 2023 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Shift4 Payments, Inc. (“Shift4” or the “Company”) (NYSE: FOUR) complied with federal securities laws. On April 19, 2023, Blue Orca Capital published a report alleging that “Shift4 engaged in…

Read More

Minister Baryomunsi Calls for Overhaul of the Office of the Prime Minister: A Necessary Step for Progress

Minister Baryomunsi: The entire Office of the Prime Minister needs reviewing and restructuring Minister for ICT and National Guidance Calls for Office of the Prime Minister Overhaul The Minister for ICT and National Guidance, Dr. Chris Baryomunsi, has recently proposed a comprehensive review and restructuring of the Office of the Prime Minister in order to…

Read More

Breaking News: Esperion Teams Up with Currax Pharmaceuticals LLC for Exciting Co-Promotion Agreement!

Esperion Announces Co-Promotion Agreement With Currax Pharmaceuticals LLC Performance-Based Agreement Provides for Currax’s Sales Representatives to Detail Esperion’s Products Reinforces Esperion’s Focus on Driving Persistent Growth By More Than Doubling Sales Team ANN ARBOR, Mich., April 19, 2023 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced an agreement with Currax Pharmaceuticals LLC that provides for…

Read More